Nomifensine (Merital, Alival) is a norepinephrine-dopamine reuptake inhibitor developed by a team at Hoechst AG in the 1960s. The drug was test marketed in the United States by Hoechst AG (now Sanofi-Aventis), i.e. a drug that increases the amount of synaptic norepinephrine and dopamine available to receptors by blocking the dopamine and norepinep...
Found on


<chemical> 8-amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline. An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute haemolytic anaemia with intravascular haemolysis resulting from its use. In...
Found on
No exact match found